내시경 수술기기 시장 : 디바이스 유형, 기술 유형, 구성 요소, 최종 사용자, 용도별 - 세계 시장 예측(2026-2032년)

The Endosurgery Device Market is projected to grow by USD 53.12 billion at a CAGR of 6.21% by 2032.

Endosurgery Devices Executive Summary

Endosurgery devices are central to the global shift from open procedures to minimally invasive surgery, supporting laparoscopic, endoscopic, robotic-assisted, energy-based, stapling, access, visualization, insufflation, suction-irrigation, and specimen retrieval workflows. Demand is supported by verified healthcare fundamentals: the Lancet Commission on Global Surgery reported that five billion people lack access to safe, affordable surgical and anesthesia care when needed, while the World Health Organization links population aging and noncommunicable diseases to rising healthcare needs across gastrointestinal, bariatric, gynecologic, urologic, colorectal, and thoracic specialties.

The endosurgery device market is increasingly shaped by clinical value rather than device volume alone. Hospitals and ambulatory surgery centers are prioritizing platforms that reduce operative variability, shorten length of stay, support infection-control protocols, and integrate with digital operating rooms. For manufacturers, competitive advantage depends on evidence-backed outcomes, surgeon ergonomics, procurement affordability, regulatory readiness, supply reliability, and the ability to support procedure-specific standardization across mature and emerging healthcare systems.

Transformative Shifts Reshaping Endosurgery

The endosurgery device landscape is being transformed by three connected forces: minimally invasive procedure expansion, digital operating room integration, and value-based purchasing. Health systems are seeking devices that improve surgical precision while reducing post-operative complications, readmissions, pain, and recovery time. This is strengthening demand for advanced visualization systems, vessel-sealing technologies, articulating instruments, powered staplers, trocar and access devices, and platforms compatible with complex laparoscopic and robotic-assisted procedures.

At the same time, reimbursement pressure and hospital capital scrutiny are reshaping vendor strategies. Manufacturers are moving from standalone device sales to procedure ecosystems that combine instruments, imaging, service contracts, clinical education, digital connectivity, and data support. Sterility, single-use versus reusable economics, supply continuity, cybersecurity, sustainability, and lifecycle cost are becoming as important as product performance, particularly as hospitals evaluate total cost of care and operating room efficiency.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating a cumulative impact across endosurgery, primarily through surgical video analytics, workflow recognition, image enhancement, training simulation, instrument tracking, automated documentation, and predictive maintenance. Regulatory agencies such as the U.S. FDA have authorized a growing number of AI-enabled medical technologies, with the strongest adoption to date in imaging, triage, and clinical decision-support applications. In endosurgery, AI is advancing more cautiously because intraoperative tools must meet high standards for safety, explainability, cybersecurity, data governance, and clinical validation.

The most practical near-term value lies in augmenting surgeons rather than replacing clinical judgment. AI-assisted visualization can help improve anatomical recognition, automated documentation can reduce administrative burden, and analytics from surgical video can support credentialing, quality improvement, and training. Over time, AI will strengthen robotic-assisted surgery, adaptive energy delivery, complication risk modeling, instrument utilization planning, and operating room throughput, provided vendors demonstrate reliable performance across diverse patients, procedures, data sources, and hospital environments.

Key Regional Insights Across Global Markets

Asia-Pacific is one of the most dynamic endosurgery regions, supported by large patient populations, expanding hospital infrastructure, rising insurance coverage, and growing adoption of laparoscopic and endoscopic procedures in China, India, Japan, South Korea, Australia, and Southeast Asia. North America remains a high-value endosurgery device market due to established minimally invasive surgery programs, strong ambulatory surgery center penetration, advanced reimbursement systems, rigorous regulatory oversight, and rapid adoption of robotic and digitally enabled operating room technologies.

Europe benefits from stringent clinical standards, strong public healthcare systems, and broad acceptance of minimally invasive surgical techniques, with procurement increasingly focused on value, sustainability, post-market evidence, and compliance with the Medical Device Regulation. Latin America is advancing through private hospital investment and growing access to bariatric, gynecologic, urologic, and gastrointestinal procedures, although affordability, reimbursement gaps, and import dependence remain constraints. The Middle East is investing in tertiary care, medical tourism, and advanced surgical centers, particularly across Gulf economies. Africa presents long-term opportunity as surgical capacity expands, but adoption depends on workforce training, financing, reliable supply chains, biomedical engineering support, and access to safe operating infrastructure.

Key Group Insights for Strategic Planning

ASEAN markets are benefiting from medical tourism, urban hospital expansion, health system modernization, and rising demand for minimally invasive procedures, especially in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is characterized by high healthcare investment, premium hospital infrastructure, and demand for advanced surgical platforms that support local specialty care, national health transformation agendas, and reduced outbound treatment. The European Union is shaped by harmonized regulatory expectations under the Medical Device Regulation, with buyers emphasizing clinical evidence, post-market surveillance, sustainability, traceability, and procurement transparency.

BRICS countries represent scale-driven opportunity, with Brazil, Russia, India, China, and South Africa combining large patient pools with uneven but improving access to surgical care and growing interest in domestic medtech capacity. G7 markets remain innovation anchors due to high procedure volumes, academic medical centers, payer sophistication, surgeon training ecosystems, and strong regulatory oversight. NATO member countries, while not a healthcare trade bloc, collectively represent many high-income health systems where surgical readiness, supply resilience, cybersecurity, interoperability, and medical technology standardization are increasingly important to hospital procurement and public-sector preparedness.

Key Country Insights for Endosurgery Devices

The United States leads in premium endosurgery adoption through high surgical volumes, ambulatory surgery center growth, robotic-assisted surgery penetration, strong clinical training networks, and FDA-regulated innovation. Canada emphasizes evidence-based adoption, health technology assessment, and public-sector procurement, while Mexico is supported by private hospital growth, medical tourism, and cross-border care. Brazil anchors Latin America with large procedural demand and an established specialist base, though currency fluctuation, reimbursement variability, and import requirements affect purchasing decisions.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong minimally invasive surgery utilization, with Germany standing out for engineering expertise and hospital capacity, France and the U.K. emphasizing clinical evaluation and public payer discipline, and Italy and Spain supporting broad laparoscopic adoption across public and private hospitals. Russia remains a large but complex market shaped by localization policy, procurement rules, sanctions exposure, and geopolitical constraints. In Asia-Pacific, China is expanding domestic medtech capability and hospital modernization, India is driven by private healthcare growth and affordability needs, Japan prioritizes quality, precision, and aging-population care, Australia maintains strong regulatory and clinical governance standards, and South Korea combines advanced hospitals with digital surgery innovation and high procedural sophistication.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated endosurgery platforms that demonstrate measurable improvements in operative efficiency, complication reduction, surgeon usability, workflow consistency, and total cost of care. Product roadmaps should align with procedure categories where minimally invasive techniques are clinically established, including bariatric, colorectal, gynecologic, urologic, thoracic, and gastrointestinal surgery, while also supporting the transition toward ambulatory, short-stay, and enhanced recovery surgical models.

Manufacturers should strengthen evidence generation through real-world studies, registry participation, usability validation, health economic analysis, and post-market surveillance. Commercial teams should tailor pricing, training, financing, and service models by region, balancing premium innovation in mature markets with durable, affordable, and easy-to-maintain devices in emerging economies. Strategic investments in AI-enabled visualization, robotic compatibility, digital workflow integration, cybersecurity, regulatory preparedness, and supply-chain resilience will be critical for long-term competitiveness in the endosurgery device industry.

Research Methodology

This executive summary is built on a structured research methodology that combines secondary research, market triangulation, and expert interpretation. Core inputs include regulatory databases, public health statistics, hospital procurement trends, clinical practice guidelines, peer-reviewed surgical literature, reimbursement frameworks, trade data, technology adoption patterns, and procedure-level signals across endosurgery device categories.

The analysis applies cross-validation across regions, procedure types, end-user settings, and product segments to reduce bias and improve reliability. Market signals are evaluated through clinical relevance, regulatory feasibility, installed base dynamics, supply-chain conditions, purchasing behavior, training requirements, and operating room workflow impact. Insights are designed to support strategic planning for manufacturers, distributors, investors, healthcare providers, and policy stakeholders evaluating the global endosurgery device market without relying on market sizing, share, or forecasting assumptions.

Conclusion

The endosurgery device market is positioned for sustained strategic importance as healthcare systems continue shifting toward minimally invasive, cost-efficient, and digitally supported surgical care. Demand is reinforced by demographic pressure, noncommunicable disease prevalence, increasing surgical access, and continued preference for procedures that reduce tissue trauma, support faster mobilization, and accelerate recovery.

Future leadership will depend on the ability to combine device performance with clinical evidence, workflow integration, training support, regulatory compliance, supply resilience, and responsible use of artificial intelligence. Organizations that can deliver safe, scalable, and economically defensible endosurgery solutions across both advanced and resource-constrained markets will be best positioned to shape the next phase of surgical innovation.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Endosurgery Device Market, by Device Type

• 7.1. Endoscopes And Visualization Systems
  • 7.1.1. Camera Systems
  • 7.1.2. Flexible Endoscopes
  • 7.1.3. Rigid Endoscopes
• 7.2. Energy Devices
  • 7.2.1. Electrosurgical Devices
  • 7.2.2. Laser Devices
  • 7.2.3. Ultrasonic Devices
• 7.3. Insufflators
• 7.4. Laparoscopic Instruments
• 7.5. Morcellators
• 7.6. Tissue Retrieval Bags

8. Endosurgery Device Market, by Technology Type

• 8.1. Conventional Endosurgery
• 8.2. AI Assisted Surgery
• 8.3. Robot Assisted Surgery
• 8.4. 3D Visualization Systems

9. Endosurgery Device Market, by Component

• 9.1. Hardware
  • 9.1.1. Instruments
  • 9.1.2. Imaging Systems
• 9.2. Software

10. Endosurgery Device Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Hospitals
• 10.3. Specialty Clinics

11. Endosurgery Device Market, by Application

• 11.1. Cardiovascular
• 11.2. ENT
• 11.3. General Surgery
• 11.4. Gynecology
• 11.5. Urology

12. Endosurgery Device Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Endosurgery Device Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Endosurgery Device Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Ambu A/S
• 16.2. Aohua Medical Technology Co Ltd
• 16.3. Applied Medical Resources Corp
• 16.4. B Braun Melsungen AG
• 16.5. Boston Scientific Corp
• 16.6. ClearCam Inc
• 16.7. CONMED Corp
• 16.8. Cook Group Inc
• 16.9. Dornier MedTech
• 16.10. Erbe Elektromedizin GmbH
• 16.11. Fujifilm Holdings Corp
• 16.12. Genicon Inc
• 16.13. Hologic Inc
• 16.14. Hoya Corp
• 16.15. Intuitive Surgical Inc
• 16.16. Johnson & Johnson
• 16.17. Medtronic plc
• 16.18. Micro Tech Endoscopy
• 16.19. Olympus Corp
• 16.20. Richard Wolf GmbH
• 16.21. ShenZhen Mindray Bio Medical Electronics Co Ltd
• 16.22. Smith & Nephew plc
• 16.23. Sonoscape Medical Corp
• 16.24. Steris plc
• 16.25. Stryker Corp
• 16.26. Teleflex Inc
• 16.27. Xion GmbH
• 16.28. Zhejiang Tiansong Medical Instrument Co Ltd